Join to View Full Profile
20 York StNew Haven, CT 06510
Phone+1 203-688-4242
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kurt Schalper, MD is a pathologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut.
Certifications & Licensure
CT State Medical License 2017 - Present
Publications & Presentations
PubMed
- Leveraging multi-modal foundation models for analysing spatial multi-omic and histopathology data.Tianyu Liu, Tinglin Huang, Tong Ding, Hao Wu, Peter Humphrey
Nature Biomedical Engineering. 2026-02-05 - 3 citationsMolecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer.Mihaela Aldea, Julia K Rotow, Maria Arcila, Matthew Hatton, Lynette Sholl
Journal of Thoracic Oncology. 2025-11-01 - 9 citationsSpatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer.Thazin N Aung, James Monkman, Jonathan Warrell, Ioannis Vathiotis, Katherine M Bates
Nature Genetics. 2025-10-01
Press Mentions
AACR Annual Meeting 2025 Plenaries: Cancer Evolution, Tumor Microenvironment, Drugging KRAS, and MoreMay 29th, 2025- Navigating the Meandering Path of Oncology Drug DevelopmentMay 28th, 2025
- Daily Takeaways from the AACR Annual Meeting 2025: Tuesday, April 29April 29th, 2025
Grant Support
- Multiplexed spatially resolved tissue biomarkers for optimal use of PD-1 axis blockers and PARP inhibitors in cancer.YALE UNIVERSITY2025–2027
- Biological and clinical significance of spatial immune heterogenenity in non-small cell lung cancerYALE UNIVERSITY2025–2027
- Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung CancerYALE UNIVERSITY2025–2027
- Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung CancerYALE UNIVERSITY2025–2027
- Understanding the role and clinical potential of dominant immune suppressive myeloid-cell responses in human cancerYALE UNIVERSITY2021–2026
